{
    "nct_id": "NCT03355560",
    "official_title": "A Single Arm Phase 2 Study of Adjuvant Nivolumab After Salvage Resection in Head and Neck Squamous Cell Carcinoma Patients Previously Treated With Definitive Therapy",
    "inclusion_criteria": "* Prior definitive therapy with radiation (with or without prior surgical resection and/or chemotherapy) who have underwent salvage resection with curative intent and have no other curable options\n* Pre-operative scans including chest imaging preferably PET/CT and CT neck w/contrast. MRI neck is acceptable if contrast contraindicated.\n* Able to provide archived biopsy or resected tissue.\n* Adequate performance status and labs.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients who did not receive at least radiotherapy as prior definitive treatment.\n* Patients who have gross measurable residual disease after surgery or those who underwent surgery for palliative purposes i.e. for symptom control.\n* Has nasopharyngeal or sinonasal carcinoma.\n* Has confirmed metastatic disease.",
    "miscellaneous_criteria": ""
}